on Q1/2018 Management’s Discussion and Analysis (MD&A) for year 2017 (Revised) 3 Executive Summary In overall 2017 performance, the Company had significant improvements in various areas such as

under the Credit Agreement since the provision of loans under the said Credit Agreement is subject to various conditions precedent as provided in 6), e.g. the Company must obtain approval from its Board

. Billboards The Company is considered as one of the first pioneer in initiating billboard business in Thailand. In the present, the Company offers various billboard formats, comprising of Large-format

service station location was 1,154 stations at the end of September 2018. The company implemented various marketing programs to push thruput per station; within this quarter the new version of the

Compensation is referencing on the negotiation between buyer and seller. The Company has set criteria to determine the Value of Compensation in various methods based on the financial status of Modern Pharma

and shareholders in various aspects such as:  Facilitate ICUK’s business operation in pursuant to the business plan that the Company believes in that ICUK would potentially generate profit in the

believes that the Change of overseas subsidiaries’ capital structure transaction could potentially result in benefits to the Company and shareholders in various aspects such as:  Facilitate ICUK’s business

stockpile storage site for accommodating the expedited construction of various projects of the Company, whereby such plots of land are adjacent to the Company’s projects so it makes transportation convenient

ordinary shares, Leyland will procure the construction company for construction of buildings and various types of houses as mentioned above and will utilize the fund for such development not exceeding THB

out of the Company’s 9-year business strategy. Throughout those 3 years until now, the Company has been investing in key various projects, including plant facilities and machinery enhancement, new